PSJH System Digestive Health Institute, Renton, WA, USA.
PSJMC MIS-Ba Service, Burbank, CA, USA.
Surg Endosc. 2022 Feb;36(2):1433-1443. doi: 10.1007/s00464-021-08428-8. Epub 2021 Apr 9.
This study was designed to define the value, cost, and fiscal impact of robotic-assisted procedures in abdominal surgery and provide clinical guidance for its routine use.
34,984 patients who underwent an elective cholecystectomy, colectomy, inguinal hernia repair, hysterectomy, or appendectomy over a 24-month period were analyzed by age, BMI, risk class, operating time, LOS and readmission rate. Average Direct and Total Cost per Case (ADC, TCC) and Net Margin per Case (NM) were produced for each surgical technique, i.e., open, laparoscopic, and robotic assisted (RA).
All techniques were shown to have similar clinical outcomes. 9412 inguinal herniorrhaphy were performed (48% open with $2138 ADC, 29% laparoscopy with $3468 ADC, 23% RA with $6880 ADC); 8316 cholecystectomies (94% laparoscopy with $2846 ADC, 4.4% RA with a $7139 ADC, 16% open with a $3931 ADC); 3432 colectomies (42% open with a $12,849 ADC, 38% laparoscopy with a $10,714, 20% RA with a $15,133); 12,614 hysterectomies [42% RA with a $8213 Outpatient (OP) ADC, 39% laparoscopy $5181 OP ADC, 19% open $4894 OP ADC]. Average Global NM is - 1% for RA procedures and only positive with commercial payors.
RA techniques do not produce significant clinical enhancements than similar surgical techniques with identical outcomes while their costs are much higher. The produced value analysis does not support the routine use of RA techniques for inguinal hernia repair and cholecystectomy. RA techniques for hysterectomies and colectomies are also performed at much higher cost than open and laparoscopic techniques, should only be routinely used with appropriate clinical justification and by cost efficient surgical providers.
本研究旨在确定机器人辅助腹部手术的价值、成本和财政影响,并为其常规应用提供临床指导。
对 24 个月内行择期胆囊切除术、结肠切除术、腹股沟疝修补术、子宫切除术或阑尾切除术的 34984 名患者进行了年龄、BMI、风险分级、手术时间、住院时间和再入院率的分析。为每种手术技术(开放、腹腔镜和机器人辅助)生成了每个病例的平均直接和总费用(ADC、TCC)和每个病例的净收益(NM)。
所有技术的临床结果均相似。共进行了 9412 例腹股沟疝修补术(48%开放,ADC 为 2138 美元;29%腹腔镜,ADC 为 3468 美元;23%机器人辅助,ADC 为 6880 美元);8316 例胆囊切除术(94%腹腔镜,ADC 为 2846 美元;4.4%机器人辅助,ADC 为 7139 美元;16%开放,ADC 为 3931 美元);3432 例结肠切除术(42%开放,ADC 为 12849 美元;38%腹腔镜,ADC 为 10714 美元;20%机器人辅助,ADC 为 15133 美元);12614 例子宫切除术[42%机器人辅助,门诊 ADC 为 8213 美元;39%腹腔镜,门诊 ADC 为 5181 美元;19%开放,门诊 ADC 为 4894 美元]。机器人辅助手术的平均全球 NM 为-1%,仅在商业支付者中为正。
机器人辅助技术与具有相同结果的类似手术技术相比,并未显著改善临床效果,但其成本要高得多。所产生的价值分析不支持常规使用机器人辅助技术进行腹股沟疝修补术和胆囊切除术。机器人辅助子宫切除术和结肠切除术的成本也远高于开放和腹腔镜技术,仅应在有适当临床依据和成本效益高的手术提供者的情况下常规使用。